Blue sclera refers to a bluish or blue-gray tint in the part of the eye that is normally white. The color change happens because the sclera is thinner or more translucent than normal, allowing the darker tissue underneath to show through. While newborns commonly have a faint blue tint that fades on its own, persistent blue sclera in older children or adults is almost always a sign that something is affecting collagen, the structural protein that gives the sclera its thickness and opacity. The list of possible causes ranges from inherited connective tissue disorders to iron deficiency to certain medications.
Why the White of the Eye Looks Blue
The sclera is a tough, fibrous coat that wraps around most of the eyeball. In healthy adults it appears white because its dense network of collagen fibers scatters light in all directions, much like a thick sheet of paper looks opaque even though paper fibers are individually translucent. Beneath the sclera lies the choroid, a layer rich in blood vessels and pigment that appears dark blue-black when viewed through thin tissue.
When the sclera is thinner than normal, or when its collagen fibers are disorganized, more short-wavelength (blue) light passes through and gets reflected back from the choroid. The result is the same physics behind why veins look blue under pale skin. Imaging studies of people with osteogenesis imperfecta have confirmed that their scleral collagen layers are measurably thinner than those of healthy individuals, and that the collagen organization itself appears abnormal.1PubMed. Polarization-sensitive optical coherence tomography and scleral collagen fiber orientation in osteogenesis imperfecta So the blue tint is not a pigment deposited in the eye. It is a transparency effect, letting you see deeper structures that are normally hidden.
Osteogenesis Imperfecta and Blue Sclera
The condition most strongly linked to blue sclera is osteogenesis imperfecta, a group of inherited disorders caused by defects in type I collagen. Because collagen is the main structural protein in bone, skin, tendons, and the sclera, a mutation that disrupts it can affect all of those tissues at once. People with OI are best known for having fragile bones that fracture easily, but the same collagen deficiency is responsible for the telltale blue hue in the whites of their eyes.
The gene most frequently involved is COL1A1, which codes for one of the two chains that twist together to form type I collagen. Mutations in this gene are the hallmark of OI Type I, the mildest and most common form, where blue sclera is a consistent finding throughout life.2PubMed Central. Blue Sclera to Brittle Bones: A Rare Case of Osteogenesis Imperfecta With Dentinogenesis Imperfecta and Nephrocalcinosis In these patients the scleral blueness remains intense from birth into adulthood and does not fade.
Other OI types tell a different story. In Type III (the most severe form compatible with survival) and Type IV (moderate severity), babies may be born with distinctly blue sclera, but the color gradually fades. By adolescence most of these individuals have sclera of normal or near-normal hue.3PubMed. Natural history of blue sclerae in osteogenesis imperfecta A systematic review of ocular findings in OI confirmed this pattern and also noted that blue sclera can appear in some patients with OI Type V, a rarer form.4PubMed Central. Ocular characteristics and complications in patients with osteogenesis imperfecta: a systematic review – Section: Sclera The fading likely reflects slow thickening of the scleral collagen over childhood, compensating partially for the underlying defect. Clinicians use this age-dependent change as one clue when trying to distinguish among OI subtypes in young children.
The Triad of Blue Sclera, Brittle Bones, and Hearing Loss
When blue sclera, bone fragility, and progressive hearing loss appear together, the combination has historically been called Van der Hoeve syndrome (sometimes Van der Hoeve–de Kleyn syndrome). It represents a specific clinical picture within osteogenesis imperfecta rather than a separate disease.5PubMed. Algodystrophy in conjunction with van der Hoeve’s syndrome The hearing loss typically develops in early adulthood and tends to be conductive, meaning it results from problems with the tiny bones of the middle ear rather than nerve damage. Those ossicles are partly made of type I collagen, so the same mutation that thins the sclera and weakens the skeleton also affects how sound is transmitted to the inner ear.6PubMed Central. Van Der Hoeve-De Kleiyn’S syndrome as a rare cause of hearing loss – two case reports
Not everyone with OI develops all three features. Blue sclera is the most visually obvious and is often the first sign a parent or doctor notices. Hearing loss may not become apparent until the second or third decade of life. Because the hearing decline is gradual, it sometimes goes unrecognized unless specifically tested for, which is why audiological screening is recommended for people with a confirmed OI diagnosis.
Dental Abnormalities That Accompany Blue Sclera
Another feature that can travel with blue sclera in OI is dentinogenesis imperfecta, a condition in which the teeth have a translucent or opalescent appearance and are unusually prone to chipping and wear. The reason is the same collagen story: dentin, the hard tissue that makes up most of each tooth, depends on type I collagen for its structure. When COL1A1 mutations disrupt collagen formation, teeth can develop with thin enamel and soft dentin, leading to rapid breakdown. A recent case report documented a patient with OI Type I who presented with blue sclera, multiple fractures, dental abnormalities, bowed long bones, short stature, and abnormal calcium metabolism all at once.7PubMed Central. Blue Sclera to Brittle Bones: A Rare Case of Osteogenesis Imperfecta With Dentinogenesis Imperfecta and Nephrocalcinosis Dentinogenesis imperfecta does not always accompany OI, but when it does, it reinforces the systemic nature of the collagen defect and underscores why blue sclera in a child with unexplained dental problems should prompt further investigation.
Brittle Cornea Syndrome and Other Connective Tissue Disorders
OI gets most of the attention, but it is not the only genetic condition that produces blue sclera. Brittle cornea syndrome is a rare autosomal recessive disorder caused by mutations in the genes ZNF469 or PRDM5, which are thought to regulate the production of several extracellular matrix components, including collagen.8PubMed Central. ZNF469 frequently mutated in the brittle cornea syndrome (BCS) is a single exon gene possibly regulating the expression of several extracellular matrix components The hallmark of BCS is extreme thinning and fragility of the cornea, the clear front surface of the eye, to the point that it can rupture spontaneously or after very minor trauma. Blue sclera, high nearsightedness, skin hyperelasticity, and joint hypermobility round out the picture.9Indian Journal of Ophthalmology – Case Reports. Brittle cornea syndrome—A rare genetic disease
While BCS is extremely rare, it matters because the eye findings can initially be mistaken for OI. The distinguishing feature is the cornea: in BCS the cornea is dangerously thin and prone to keratoconus or keratoglobus, whereas in OI the cornea is usually normal or only mildly affected. Some forms of Ehlers-Danlos syndrome, another group of connective tissue disorders, can also produce a faint blue scleral tint along with joint hypermobility and skin fragility, though blue sclera tends to be less prominent in those conditions than in OI or BCS.
Iron Deficiency and Blue Sclera
One of the more surprising associations is between blue sclera and iron deficiency, a condition that has nothing to do with collagen genes. The proposed mechanism is that iron is a cofactor for prolyl hydroxylase, an enzyme involved in collagen synthesis. When iron levels drop low enough, collagen production in the sclera slows down, potentially thinning it and allowing the blue-tinged choroid to show through. This link has been discussed in medical textbooks for decades, but the evidence has always been somewhat thin.
A pilot study tried to put numbers on the relationship. Physicians were asked to judge whether patients’ sclera appeared blue, and those assessments were compared with lab-confirmed iron deficiency. One physician’s subjective rating correctly identified iron-deficient patients with a positive predictive value of about 86%, though the overall sensitivity was only around 61%. Computer-based color analysis of scleral photographs performed slightly better in sensitivity, picking up roughly 78% of iron-deficient patients, but with lower specificity.10PubMed Central. Computed and Subjective Blue Scleral Color Analysis as a Diagnostic Tool for Iron Deficiency: A Pilot Study The study was small, and the authors framed the findings as preliminary. Still, it suggests the connection is real, even if blue sclera is not reliable enough on its own to serve as a screening tool for anemia. If you are iron deficient and notice a blue tint in your eyes, correcting the deficiency with supplementation should eventually reverse it, since the scleral thinning is acquired rather than genetic.
Medications That Can Change Scleral Color
Certain drugs can produce blue or blue-gray discoloration of the sclera through entirely different mechanisms than collagen thinning. Minocycline, a tetracycline antibiotic commonly prescribed for acne and certain infections, is one of the best-documented offenders. Long-term use can cause pigment deposits in the sclera, skin, nails, and even bone. A case report described an elderly patient who came in for a routine eye exam complaining of blue discoloration in the whites of his eyes and was found to have bilateral blue scleral pigmentation along with blue discoloration in other areas of skin.11PubMed. Minocycline-Induced Scleral and Dermal Hyperpigmentation Unlike the translucency-based blue of OI, minocycline deposits actual pigmented material into the tissue. The discoloration may fade slowly after stopping the drug, but it does not always resolve completely.
Systemic corticosteroids are another medication class linked to blue sclera, though this effect is far less common and is primarily reported in children. A review of ocular complications of corticosteroids listed blue sclera in children among the less frequent side effects, alongside more widely recognized problems like elevated eye pressure and cataracts.12Dermatologic Clinics. Ocular Complications of Topical, Periocular, and Systemic Corticosteroids The mechanism is not fully understood, but corticosteroids are known to affect collagen turnover in various tissues, so scleral thinning is a plausible explanation.
When Blue-Tinged Sclera Is Normal
Before anyone panics after studying their eyes in the bathroom mirror, it is worth knowing that a faint bluish tint to the sclera is extremely common in healthy newborns and infants. A baby’s sclera is naturally thinner than an adult’s, and it gradually thickens over the first year or two of life. This is why many parents notice a subtle blue cast in their newborn’s eyes that disappears without treatment. The blue hue in a healthy baby is usually uniform, mild, and accompanied by no other symptoms.
What distinguishes a benign infant finding from something that warrants medical attention is persistence and intensity. If the blue tint is strikingly deep, stays vivid past early infancy, or is accompanied by other signs like fractures from minor falls, unusually flexible joints, translucent teeth, or a family history of bone fragility, further evaluation is warranted. Eye color alone is not diagnostic of anything. The clinical context, meaning what else is going on with the child, is what matters.
Adults with very fair skin and light-colored eyes may also notice a faintly blue or gray appearance in certain lighting conditions. This is typically normal variation in scleral thickness and has no medical significance. The concern arises when the blue tint is new, deepening, or bilateral and symmetric, all of which suggest a systemic process rather than a trick of the light.
How Clinicians Investigate Blue Sclera
Blue sclera itself is an observation, not a diagnosis. The clinical detective work lies in figuring out why the sclera is blue. A careful physical exam looks for associated features: fractures or bowed limbs, short stature, abnormal teeth, hearing loss, skin elasticity, and joint flexibility. The pattern of accompanying findings usually narrows the list of possibilities quickly. If OI is suspected, genetic testing for COL1A1 and COL1A2 mutations can confirm the diagnosis and identify the subtype, which helps predict how severe the disease course will be.
Imaging has added another dimension. Polarization-sensitive optical coherence tomography can measure the thickness and organization of individual scleral layers in living patients, offering a way to quantify the structural changes behind the blue color rather than relying on visual impression alone.13PubMed. Polarization-sensitive optical coherence tomography and scleral collagen fiber orientation in osteogenesis imperfecta This technology is still in its research phase and is not part of routine clinical care, but it points toward a future where scleral imaging could help distinguish among the various conditions that produce similar outward appearances.
For drug-induced cases, the history usually makes the diagnosis straightforward. A patient on long-term minocycline who develops bilateral blue sclera alongside skin discoloration does not typically need genetic testing; stopping or switching the medication and observing for improvement is the usual first step.
Blue Sclera in Animals
Osteogenesis imperfecta is not limited to humans. The same collagen defect has been documented in several animal species, and it produces strikingly similar features. Newborn Romney lambs with a lethal form of OI were described as having dark blue sclera along with joint laxity, small teeth, and skin fragility, all consistent with a fundamental defect in collagen production by fibroblasts.14PubMed. Lethal osteogenesis imperfecta and skin fragility in newborn New Zealand Romney lambs Holstein-Friesian calves have been found with OI as well, presenting with multiple fractures, bone deformities, dentinogenesis imperfecta, and light blue sclera.15PubMed. Osteogenesis imperfecta in Holstein-Friesian calves
These animal cases are more than curiosities. They serve as natural models for studying how collagen mutations play out across different species and tissues. The fact that the same mutation produces the same combination of brittle bones, fragile skin, dental problems, and blue sclera in lambs, calves, and humans underscores how deeply conserved the role of type I collagen is across mammals. For veterinarians, recognizing blue sclera in a newborn animal with unexplained fractures can lead to a faster diagnosis and a more humane outcome, since lethal forms of OI in animals typically cause severe suffering.